pMDIs and DPIs Flashcards

1
Q

Pressurized metered dose inhaler

A

Delivers drugs for multiple dosing using metering valves with the help of PROPELLANTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Major components of pMDI

A

Container
Metering valve (25-100 microL)
Spray actuator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Formulation for pMDI

A

Drug
Propellants
Surfactants and lubes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Surfactants are used for?

A

To disperse drug particles in suspension or lube the valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does the acutator do?

A

Provides an orifice for discharge of spray to patient’s mouth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How doe pMDIs work?

A

Aersolization begins with propellants leave the actuator as a plume due to vaporization
Particle size decreases rapidly due to evaporation as the cloud moves away from the nozzel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Breath actuated MDIs?

A

Reduce or eliminate the hand-breath coordination
Senses the patient inhalation through the actuator and fire the inhaler automatically
- Autohaler

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Autohaler

A

Patient life to prime the device before inhalation

Patients press and breathe at the same time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Propellant free MDIs

A

Produce aerosols without propellants

- Respimat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Respimat?

A

Transform aqueous solution to liquid aerosol droplets

Propellant free multi-dose hand held inhaler

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Correct use of pMDIs?

A

Shake before inhalation

Prime several times to make sure there aren’t erratic first sprays

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Spacer devices?

A

Reduce oropharyngela deposition and increase lung deposition
Increase distance between point of spray and mouth
Faster particles will strike the container
Reduce or eliminate the coordination between actuation and inhalation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Medical benefit of spacer devices?

A

Reduces the risk of oral candiasis and dysphonia with inhaled corticosteroids
Reduce potential systemic absorption from GIT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Disadvantages of spacer devices?

A

Cumbersome
Reduce dose bc of electrostatic charge
- Charge removed by priming chamber or washing with ionic detergent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Types of spacers?

A

Simple tube extension
Valved holding chamber
Reverse flow device

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Valved holding chamber

A

One way valve for the aerosol to remain within the device until patients inhales
- Helps prevent blowing away the dose

17
Q

Reverse flow devices

A

Use a bag which collapses upon inhalation

Use a chamber with air vent that opens during inhalation

18
Q

Dry powder inhalers

A

Contain solid drug suspended in a dry powder mix that can be fluidized when patients inhales

  • Micronized drug particles with larger carrier particles
  • Powders are solid when static, liquid when they flow
19
Q

Carriers?

A

Prevent aggregation and improve flow

20
Q

Dry powder inhaler particle movement?

A

Passive or active

21
Q

Passive

A

Patients activate and inhale
- Breath actuated
Inhalation: airflow creates shear and turbulence and air is introduced in the powder bed -> fluid and enters patient
- Deep in the lungs but deposition depends on patient’s inspiratory airflow

22
Q

Active

A

Power assisted

  • Pneumatic, impact force and vibratory
  • Drugs with narrow therapeutic windows
  • Spiros and Microdose
23
Q

Excipients in DPIs?

A

Lactose
Mannitol and Glucose
OR none (plumicort and turbuhaler)

24
Q

Lactose

A

improves handling, dispensing and metering of the drug by reducing cohesive forces between drug particles

25
Q

Large porous particles for DPIs

A

Aerodynamic diameter is smaller than their volume diameter

Made in the respiratory aerdynamic diameter range (even if they are 20 micrometers)

26
Q

PulmoSpheres (Large porous particles)

A

Low density particles
Lesser susceptibility to phagocytosis
Lesser aggregation
- Tobi-Podhaler

27
Q

Unit dose with drug in hard gelatin capsules

A

Placed individually in device

- Handihaler

28
Q

Multidose with drug in foil blister

A

Loaded by patient

- Diskhaler

29
Q

Multi-dose with drug preloaded in the devide

A

Preloaded and sealed

- Diskus

30
Q

Reservoir type of device

A

A dose is measured and delivered from a drug reservoir

  • Metering cups are filled by gravity from reservoir and delivered to an inhalation passage
  • Clickhaler
31
Q

Diskhaler

A

Multidose
Reloadable
- Pierce the foil to release the dose

32
Q

Diskus

A

Dosage pack sealed during manufacturing

Wheels guide the foil strips and aligns each newly opened blister with air passageways

33
Q

Nebulizers Advantages

A

No specific inhalation technique or coordination required
Aerozolizes most drug solutions
Deliver large doses
Good for infants or sick patients

34
Q

Nebulizers Disadvantages

A
Time consuming
Bulky
Non-portable
Easy contaminated
Poor delivery efficiency
Drug wastage
Huge variation
35
Q

pMDIs Advantages

A
Compact 
Portable
Multi-dose
Inexpensive
Sealed environment
Reproducible dosing
36
Q

pMDIs Disadvantages

A

Partient coordination
High oral deposition
5 mg max dose
Limited range of drug available

37
Q

DPIs Advantages

A
Compact
Portable
Breath actuated
Easy to use
No coordination
38
Q

DPIs Disadvantages

A

Respirable dose dependent on inspiration
Humidity: aggregation
Lose the dose if exhale into the device
Contains lactose

39
Q

Inhaled Insulin Exubera

A

Rapid acting insulin
Blister packages
No longer used